摘要
对我国目前药物临床试验伦理审查存在的问题进行了分析,并提出通过建立完善的伦理审查程序和审查标准,加强伦理委员会成员的培训,加大国际间的交流及监管力度等措施,提高伦理审查的质量和水平,以保障受试者的合法权益和临床研究的科学性和可靠性。
To make the pharmaceutical clinical trials meet the ethic standard in our country, we make an analysis of the problems of current ethics censorship in this field. Moreover, we claim that for the purpose of scientific and reliable clinical research, the legal rights of subjects and the quality increase of ethics censorship, it is necessary to establish complete ethics censorship procedure and standard, intensify the training of the ethics committee's members, set up supervisory system and promote international community.
出处
《中国医学伦理学》
2007年第1期35-36,共2页
Chinese Medical Ethics
关键词
药物临床试验
伦理审查
受试者
pharmaceutical clinical trial
ethic censorship
subject